Literature DB >> 16601071

The role of c-Jun N-terminal kinase, p38, and extracellular signal-regulated kinase in insulin-induced Thr69 and Thr71 phosphorylation of activating transcription factor 2.

Bart Baan1, Hans van Dam, Gerard C M van der Zon, J Antonie Maassen, D Margriet Ouwens.   

Abstract

The stimulation of cells with physiological concentrations of insulin induces a variety of responses, e.g. an increase in glucose uptake, induction of glycogen and protein synthesis, and gene expression. One of the determinants regulating insulin-mediated gene expression may be activating transcription factor 2 (ATF2). Insulin activates ATF2 by phosphorylation of Thr69 and Thr71 via a two-step mechanism, in which ATF2-Thr71 phosphorylation precedes the induction of ATF2-Thr69+71 phosphorylation by several minutes. We previously found that in c-Jun N-terminal kinase (JNK)-/- fibroblasts, cooperation of the ERK1/2 and p38 pathways is required for two-step ATF2-Thr69+71 phosphorylation in response to growth factors. Because JNK is also capable of phosphorylating ATF2, we assessed the involvement of JNK, ERK1/2 and p38 in the insulin-induced two-step ATF2 phosphorylation in JNK-expressing A14 fibroblasts and 3T3L1-adipocytes. The induction of ATF2-Thr71 phosphorylation was sensitive to MAPK kinase (MEK) 1/2-inhibition with U0126, and this phosphorylation coincided with nuclear translocation of phosphorylated ERK1/2. Use of the JNK inhibitor SP600125 or expression of dominant-negative JNK-activator SAPK kinase (SEK1) prevented the induction of ATF2-Thr69+71, but not ATF2-Thr71 phosphorylation by insulin. ATF2-dependent transcription was also sensitive to SP-treatment. Abrogation of p38 activation with SB203580 or expression of dominant-negative MKK6 had no inhibitory effect on these events. In agreement with this, the onset of ATF2-Thr69+71 phosphorylation coincided with the nuclear translocation of phosphorylated JNK. Finally, in vitro kinase assays using nuclear extracts indicated that ERK1/2 preceded JNK translocation. We conclude that sequential activation and nuclear appearance of ERK1/2 and JNK, rather than p38, underlies the two-step insulin-induced ATF2 phosphorylation in JNK-expressing cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16601071     DOI: 10.1210/me.2005-0289

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  12 in total

Review 1.  Uses for JNK: the many and varied substrates of the c-Jun N-terminal kinases.

Authors:  Marie A Bogoyevitch; Bostjan Kobe
Journal:  Microbiol Mol Biol Rev       Date:  2006-12       Impact factor: 11.056

Review 2.  ATF2, a paradigm of the multifaceted regulation of transcription factors in biology and disease.

Authors:  Gregory Watson; Ze'ev A Ronai; Eric Lau
Journal:  Pharmacol Res       Date:  2017-02-15       Impact factor: 7.658

3.  Developmental regulation of TAC1 in peptidergic-induced human mesenchymal stem cells: implication for spinal cord injury in zebrafish.

Authors:  Nitixa Patel; Tilman E Klassert; Steven J Greco; Shyam A Patel; Jessian L Munoz; Bobby Y Reddy; Margarette Bryan; Neil Campbell; Natalia Kokorina; Hatem E Sabaawy; Pranela Rameshwar
Journal:  Stem Cells Dev       Date:  2011-07-26       Impact factor: 3.272

4.  C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells.

Authors:  Mahua Choudhury; Ishtiaq Qadri; Shaikh Mizanoor Rahman; Jill Schroeder-Gloeckler; Rachel C Janssen; Jacob E Friedman
Journal:  Mol Cell Endocrinol       Date:  2010-08-24       Impact factor: 4.102

5.  Identification of a novel amino acid response pathway triggering ATF2 phosphorylation in mammals.

Authors:  Cédric Chaveroux; Céline Jousse; Yoan Cherasse; Anne-Catherine Maurin; Laurent Parry; Valérie Carraro; Benoit Derijard; Alain Bruhat; Pierre Fafournoux
Journal:  Mol Cell Biol       Date:  2009-10-12       Impact factor: 4.272

6.  Megakaryocytic Maturation in Response to Shear Flow Is Mediated by the Activator Protein 1 (AP-1) Transcription Factor via Mitogen-activated Protein Kinase (MAPK) Mechanotransduction.

Authors:  Stephanie A Luff; Eleftherios T Papoutsakis
Journal:  J Biol Chem       Date:  2016-01-26       Impact factor: 5.157

7.  A cytoplasmic negative regulator isoform of ATF7 impairs ATF7 and ATF2 phosphorylation and transcriptional activity.

Authors:  Jessica Diring; Barbara Camuzeaux; Mariel Donzeau; Marc Vigneron; Manuel Rosa-Calatrava; Claude Kedinger; Bruno Chatton
Journal:  PLoS One       Date:  2011-08-16       Impact factor: 3.240

8.  Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers.

Authors:  Lambert C M Ngoka
Journal:  Proteome Sci       Date:  2008-10-24       Impact factor: 2.480

9.  Retinoic acid decreases ATF-2 phosphorylation and sensitizes melanoma cells to taxol-mediated growth inhibition.

Authors:  Ying Huang; Jennifer Minigh; Sarah Miles; Richard M Niles
Journal:  J Mol Signal       Date:  2008-02-12

10.  Immunosuppressant MPA Modulates Tight Junction through Epigenetic Activation of MLCK/MLC-2 Pathway via p38MAPK.

Authors:  Niamat Khan; D V Krishna Pantakani; Lutz Binder; Muhammad Qasim; Abdul R Asif
Journal:  Front Physiol       Date:  2015-12-22       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.